For most young people, a medical pathway will not be the best way to manage their gender-related distress, the report concluded.
The N.H.S. will no longer offer drugs that block puberty, except for patients enrolled in clinical research. And the report recommended that hormones like testosterone and estrogen, which spur permanent physical changes, be prescribed to minors with extreme caution.
England's move is part of a broader shift in northern Europe, where health officials have been concerned by soaring demand for adolescent gender treatments in recent years.
In 2020, Finland's health agency restricted the care by recommending psychotherapy as the primary treatment for adolescents with gender dysphoria. Two years later, Sweden restricted hormone treatments to exceptional cases.
[
add
]
[
|
|
...
]